Showing 1 - 10 of 1,080
. We reviewed recent appraisals of a pharmaceutical manufacturer in three major European markets (France; Italy; Germany … current management of the condition (unmet need, Italy), the regulatory status (Orphan Designation, Germany), as well as … medicines was 63 (Germany), 459 (Italy), and 557 days (France). Conclusions: The clinical domains of the EUnetHTA framework are …
Persistent link: https://www.econbiz.de/10011942836
In the majority of children and adolescents with epilepsy, optimal drug therapy adequately controls their condition. However, among the remaining patients who are still uncontrolled despite mono-, bi- or tri-therapy with chronic anti-epileptic treatment, a rescue medication is required. In...
Persistent link: https://www.econbiz.de/10010528456
Persistent link: https://www.econbiz.de/10011868947
Persistent link: https://www.econbiz.de/10003787586
Persistent link: https://www.econbiz.de/10003899942
debt maturity ratios. Our evidence indicate that firms in countries that are viewed as more corrupt tend to use less equity … financial claimants tend to have capital structures with more equity, and relatively more long-term debt. In addition, the …
Persistent link: https://www.econbiz.de/10008688754
Persistent link: https://www.econbiz.de/10003978337
Persistent link: https://www.econbiz.de/10003949745
Persistent link: https://www.econbiz.de/10003619850
Persistent link: https://www.econbiz.de/10003582571